Product Images Levalbuterol

This text seems to be a mixture of medicine instructions, product labeling, and some random characters and numbers. The medicine is called "Rite Pharmaceuticals" and comes in a 25 x 3 mL Sterile Unit-Dose Vials package, with 0.31 mg for oral inhalation only. There are some unidentifiable characters and non-English phrases included in the text, making it difficult to provide a complete description.*

This is a medication for inhalation called "Lavalbutsrol inhalation Solution, USP", with NDC code 7620470025. There is also a string of characters "T R0 000 ) g ST oy TR X" and "Arug voparen 160 1" which are not understandable and may be a result of poor quality.*

Levalbuterol Inhalation Solution, USP is a medication for oral inhalation only. The solution comes in 25 x 3 mL sterile unit-dose vials, which comprises 5 pouches of 5 - 3 mL vials each. The NDC code for this medication is 76204-800-55, which specifies that it is Ritedgse Pharmaceuticals' product. The medication has a concentration of 0.63 mg/3mL.*

This is a label of a pharmaceutical product intended for oral inhalation. It has the NDC code 76204-900-55 and contains 25 x 3 mL Sterile Unit-Dose Vials (5 pouches of 5 - 3 mL vials each) with a dosage strength of 1.25 mg (0.042%). The product is manufactured by RITEDGSE PHARMACEUTICALS. There are additional characters that do not form meaningful words or sentences.*

This is a drug label for levalbuterol inhalation solution, USP with a concentration of 1.25 mg (0.042%) of levalbuterol in each 3mL unit-dose vial. The solution also contains sodium chloride, edetate disodium, and sulfuric acid for pH adjustment. The solution does not contain preservatives, and the foil pouch, once opened, keeps the vials usable for two weeks, while the individual vials remain usable for only one week. It is made by Ritedose Pharmaceuticals LLC and should be used only as directed by a physician. It is stored at USP controlled room temperature (20°-25°C) and protected from light. The pouch encloses "Patient Information Leaflet" that should be dispensed with the drug. *

This is the description of a medication named Levalbuterol Inhalation Solution, USP. The information provided includes details about the drug such as dosage, concentration, and usage instructions. The medication is available in a 3mL unit-dose vial and contains 0.63mg of levalbuterol per dose. The solution is meant for oral inhalation only and should be stored at room temperature. The medication comes with a patient information leaflet that should be detached from the package insert and dispensed along with the product. The manufacturer is Ritedose Pharmaceuticals, LLC.*

Levalbuterol Inhalation Solution is a medication used for oral inhalation only. The solution is contained in a 3mL unit-dose vial, which contains 1.25 mg of levalbuterol, as well as sodium chloride, edetate disodium, and sulfuric acid to adjust the pH of the solution to 4.0. The solution has no preservatives and should be used as directed by a physician, without exceeding recommended dosage. The medication should be protected from light and stored at 20-25°C (68-77°F). The vials should remain in their protective foil pouches until use, after which they should be used within one week. The medication is produced by Ritedose Pharmaceuticals, LLC, and the consult of physicians is recommended before usage. Not-Available.*

The text describes a visual element in a unit-dose vial where a shaded area is used to indicate the twist-off tah portion.*

The text is readable but there is not enough information to generate a useful description. It appears to be a label or title of a product, possibly a face mask called "Reservoir II".*